Amanta Healthcare Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock hit its upper circuit price limit of Rs 186.51, representing a 4.85% gain within the 5% price band allowed for the day. This ceiling effectively froze trading at the peak price, signalling that demand exceeded what the price band could accommodate. The total traded volume was 1.64632 lakh shares, with a turnover of approximately Rs 3.02 crore. The narrow intraday range from Rs 171.00 to Rs 186.51 shows the stock steadily climbed before hitting the circuit, leaving buyers unable to transact beyond this level. What does the full demand picture look like for Amanta Healthcare Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Delivery volumes provide the clearest insight into the quality of this move. On 19 Aug, delivery volume rose sharply to 10,830 shares, a 72.23% increase over the 5-day average delivery volume. This surge indicates that shares traded were largely taken into investors' demat accounts, reflecting genuine buying conviction rather than intraday speculative trading. Although total traded volume was somewhat suppressed due to the circuit lock, the rising delivery volume suggests that the buying pressure was backed by investors willing to hold the stock long term. Is Amanta Healthcare Ltd's upper circuit surge driven by conviction or thin liquidity?

Moving Averages and Trend Context

Amanta Healthcare Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend preceding the circuit event. The weighted average price was closer to the high price, indicating that most volume was transacted near the upper end of the day's range. This technical backdrop supports the view that the upper circuit was not a sudden spike but rather the culmination of a sustained upward momentum. The stock has also been on a five-day consecutive gain streak, rising 21.68% over this period, further reinforcing the trend strength.

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 687 crore, Amanta Healthcare Ltd is classified as a micro-cap stock. This segment typically experiences thinner liquidity and more pronounced price swings, making upper circuit hits more frequent and impactful. The stock's liquidity profile shows it is liquid enough for a trade size of Rs 0.08 crore based on 2% of the 5-day average traded value. While this suggests some capacity for institutional participation, the limited trade size highlights the liquidity risk inherent in micro-cap stocks. Investors should be mindful that entering or exiting sizeable positions could be challenging due to thin order books and limited depth. With near-zero liquidity and a Rs 687 crore market cap, should you be chasing Amanta Healthcare Ltd?

Intraday Price Action

The stock's intraday range was Rs 171.00 to Rs 186.51, with the weighted average price skewed towards the high end. This pattern is typical for circuit hits, where the price gradually climbs before the circuit locks trading at the ceiling. The narrow range near the upper limit indicates persistent buying interest throughout the session, with sellers unwilling to offer shares below the circuit price. This behaviour further emphasises the unfilled demand and the mechanical nature of volume suppression on circuit days.

Fundamental Context

Amanta Healthcare Ltd operates in the Pharmaceuticals & Biotechnology sector, a space known for its growth potential and volatility. While the stock is trading close to its 52-week high — just 1.34% shy of Rs 189 — the recent price action reflects a strong technical momentum rather than a fundamental re-rating. The sector gained 0.27% on the day, and the Sensex rose 0.56%, making Amanta Healthcare Ltd's 4.71% gain a clear outperformance.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at a 5% gain capped the session for Amanta Healthcare Ltd, but the buying pressure remained unabated. The significant rise in delivery volume by over 70% against the recent average confirms that the move was supported by genuine investor conviction rather than mere speculative trading. Coupled with the stock trading above all major moving averages and a steady five-day gain streak, the technical picture is robust. However, the micro-cap status and limited liquidity pose a cautionary note — the stock’s order book depth and trade size capacity remain constrained, which could amplify volatility and impact the ease of entering or exiting positions. After a 5% single-day gain at upper circuit, is Amanta Healthcare Ltd still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →